Prednisone

Title	Average Rating
MATH+ Hospital Treatment Protocol for COVID-19	100.00%
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ......	95.00%
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.	90.00%
I-RECOVER Management Protocol for Long Haul COVID-19 Syndrome (LHCS)	80.00%
Durable responses with the antiangiogenic metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma	70.00%
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory.......	70.00%
The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas.'	70.00%
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r	70.00%

Languages